Discovery of multifold modified sialosides as human CD22/siglec-2 ligands with nanomolar activity on B-cells
Sialic acids are abundant in higher domains of life and lectins recognizing sialosaccharides are heavily involved in the regulation of the human immune system. Modified sialosides are useful tools to explore the functions of those lectins, especially members of the Siglec (sialic acid binding immuno...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
7 May 2014
|
| In: |
ACS chemical biology
Year: 2014, Jahrgang: 9, Heft: 7, Pages: 1444-1450 |
| ISSN: | 1554-8937 |
| DOI: | 10.1021/cb400952v |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1021/cb400952v
|
| Verfasserangaben: | Horst Prescher, Astrid Schweizer, Elena Kuhfeldt, Lars Nitschke, and Reinhard Brossmer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1727514157 | ||
| 003 | DE-627 | ||
| 005 | 20230426130554.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200820s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/cb400952v |2 doi | |
| 035 | |a (DE-627)1727514157 | ||
| 035 | |a (DE-599)KXP1727514157 | ||
| 035 | |a (OCoLC)1341355790 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Prescher, Horst |e VerfasserIn |0 (DE-588)1167703855 |0 (DE-627)1031226583 |0 (DE-576)511220758 |4 aut | |
| 245 | 1 | 0 | |a Discovery of multifold modified sialosides as human CD22/siglec-2 ligands with nanomolar activity on B-cells |c Horst Prescher, Astrid Schweizer, Elena Kuhfeldt, Lars Nitschke, and Reinhard Brossmer |
| 246 | 3 | 0 | |a two |
| 264 | 1 | |c 7 May 2014 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 20.08.2020 | ||
| 520 | |a Sialic acids are abundant in higher domains of life and lectins recognizing sialosaccharides are heavily involved in the regulation of the human immune system. Modified sialosides are useful tools to explore the functions of those lectins, especially members of the Siglec (sialic acid binding immunoglobulin like lectin) family. Here we report design, synthesis, and affinity evaluation of novel sialoside classes with combined modification at positions 2, 4, and 9 or 2, 3, 4, and 9 of the sialic acid scaffold as human CD22 (human Siglec-2) ligands. They display up to 7.5 × 105-fold increased affinity over αMe Neu5Ac (the minimal Siglec ligand). CD22 is a negative regulating coreceptor of the B-cell receptor (BCR). In vitro experiments with a human B-lymphocyte cell line showed functional blocking of CD22 upon B-cell receptor (BCR) stimulation in the presence of nanomolar concentrations of the novel ligands. The observed increased Ca2+ response corresponds to enhanced cell activation, providing an opportunity to therapeutically modulate B-lymphocyte responses, e.g., in immune deficiencies and infections. | ||
| 700 | 1 | |a Brossmer, Reinhard |d 1925-2020 |e VerfasserIn |0 (DE-588)1115343556 |0 (DE-627)869722298 |0 (DE-576)324407076 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Chemical Society |t ACS chemical biology |d Washington, DC : Soc., 2006 |g 9(2014), 7, Seite 1444-1450 |h Online-Ressource |w (DE-627)507526732 |w (DE-600)2221735-6 |w (DE-576)252159918 |x 1554-8937 |7 nnas |
| 773 | 1 | 8 | |g volume:9 |g year:2014 |g number:7 |g pages:1444-1450 |g extent:7 |a Discovery of multifold modified sialosides as human CD22/siglec-2 ligands with nanomolar activity on B-cells |
| 856 | 4 | 0 | |u https://doi.org/10.1021/cb400952v |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200820 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 1115343556 |a Brossmer, Reinhard |m 1115343556:Brossmer, Reinhard |d 140000 |e 140000PB1115343556 |k 0/140000/ |p 5 |y j | ||
| 999 | |a KXP-PPN1727514157 |e 3741301191 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1021/cb400952v"],"eki":["1727514157"]},"origin":[{"dateIssuedDisp":"7 May 2014","dateIssuedKey":"2014"}],"name":{"displayForm":["Horst Prescher, Astrid Schweizer, Elena Kuhfeldt, Lars Nitschke, and Reinhard Brossmer"]},"relHost":[{"origin":[{"publisherPlace":"Washington, DC","dateIssuedKey":"2006","publisher":"Soc.","dateIssuedDisp":"2006-"}],"id":{"zdb":["2221735-6"],"eki":["507526732"],"issn":["1554-8937"]},"name":{"displayForm":["American Chemical Society"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"ACS chemical biology","subtitle":"web edition","title":"ACS chemical biology"}],"pubHistory":["1.2006 -"],"part":{"pages":"1444-1450","issue":"7","year":"2014","extent":"7","volume":"9","text":"9(2014), 7, Seite 1444-1450"},"titleAlt":[{"title":"Chemical biology"}],"disp":"American Chemical SocietyACS chemical biology","note":["Gesehen am 18.11.08"],"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"role":"aut","display":"American Chemical Society","roleDisplay":"VerfasserIn"}],"language":["eng"],"recId":"507526732"}],"physDesc":[{"extent":"7 S."}],"title":[{"title_sort":"Discovery of multifold modified sialosides as human CD22/siglec-2 ligands with nanomolar activity on B-cells","title":"Discovery of multifold modified sialosides as human CD22/siglec-2 ligands with nanomolar activity on B-cells"}],"person":[{"family":"Prescher","given":"Horst","roleDisplay":"VerfasserIn","display":"Prescher, Horst","role":"aut"},{"family":"Brossmer","given":"Reinhard","display":"Brossmer, Reinhard","roleDisplay":"VerfasserIn","role":"aut"}],"language":["eng"],"recId":"1727514157","note":["Gesehen am 20.08.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a PRESCHERHODISCOVERYO7201 | ||